Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage ...

Gemini AI serves as a powerful tool for researching day trade strategies but cannot be used to execute trades directly. It summarizes fundamentals and compares assets to support daily trade decisions ...

The government’s targets have fallen short of what some experts say is needed to achieve net zero by 2050. But others say reaching them would still be ‘an enormous transformation’ and account for ...